# Phreesia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phreesia

- Industry: Healthcare IT
- Headquarters: Wilmington, US
- Website: www.phreesia.com
- Total disclosed funding: $73M
- Latest round: Series E (Oct 27, 2014)
- Investors on record: 9

## About

Phreesia, Inc. is a healthcare technology company that provides patient intake software solutions to enhance registration processes and patient engagement, ultimately optimizing operational efficiency for healthcare organizations across North America.Founded in 2005 and headquartered in Wilmington, US, Phreesia, Inc. specializes in patient intake solutions for healthcare providers. The company has undergone significant growth and its most recent funding round was a Private Placement/FOLLOW ON in July 2021, raising USD 225.00 mn. Evan Roberts is the founder, while Chaim Indig serves as the CEO. Phreesia has successfully completed 15 deals to date, with the latest occurring on July 17, 2019.Phreesia offers an extensive range of patient intake software solutions aimed at streamlining the healthcare registration process. Their core product supports mobile and in-office registration, specialty-specific workflows, online appointment scheduling, referrals, and patient tracking. These solutions are designed to enhance patient engagement and optimize operational efficiency in diverse healthcare settings, including health systems and community clinics across the US and Canada.In the most recent fiscal year, Phreesia reported a revenue of USD 419.81 mn, with an EBITDA of USD -29.98 mn. The company primarily generates revenue through subscription-based models, allowing healthcare providers to access their extensive suite of patient intake software and related services, which are tailored to various healthcare settings.Phreesia aims to expand its product offerings and enhance its market reach. The company is actively working on the development of new software functionalities to be rolled out in the upcoming year. Additionally, Phreesia intends to penetrate further into the Canadian market and explore opportunities in other North American regions by 2025. The recent funding of USD 225 mn will support these initiatives, allowing Phreesia to innovate and optimize its service offerings while strengthening its presence in existing markets.

## Funding rounds

- Series E, Oct 27, 2014, $28M — LLR Partners, HLM Venture Partners, Ascension Ventures
- Series D, Sep 28, 2010, $4.8M — VantagePoint Capital
- Series D, May 25, 2010, $15M — Polaris Partners, LRVHealth, HLM Venture Partners, Ascension Ventures, BlueCross BlueShield Venture Partners, Sandbox Industries
- Series C, Feb 2, 2009, $12M — Polaris Partners, LRVHealth, HLM Venture Partners, BlueCross BlueShield Venture Partners, Sandbox Industries
- Series B, Aug 30, 2007, $10M — Polaris Partners, LRVHealth, HLM Venture Partners, Village Ventures
- Series A, Dec 1, 2006, $0.9M — LRVHealth, HLM Venture Partners
- Series A, Aug 18, 2006, $2M — HLM Venture Partners

## Investors

- HLM Venture Partners (https://capitalatlas.ai/funds/hlm-venture-partners) — Series A, Series B, Series C, Series D, Series E
- LRVHealth (https://capitalatlas.ai/funds/lrvhealth) — Series A, Series B, Series C, Series D
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series B, Series C, Series D
- Village Ventures (https://capitalatlas.ai/funds/village-ventures) — Series B
- BlueCross BlueShield Venture Partners (https://capitalatlas.ai/funds/bluecross-blueshield-venture-partners) — Series C, Series D
- Sandbox Industries (https://capitalatlas.ai/funds/sandbox-industries) — Series C, Series D
- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series D, Series E
- VantagePoint Capital (https://capitalatlas.ai/funds/vantagepoint-capital) — Series D
- LLR Partners (https://capitalatlas.ai/funds/llr-partners) — Series E